Q3 sales rose +8% to €2,921m and the gross profit margin improved from 26.9% to 29.7%, based on IFRS. EBIT rocketed +67% to €360m and net profit attributable to shareholders ballooned by +71% to €176m. Conveying the better operating performance and higher D/A down the road, operating CF strongly increased by +31% to €522m. Investing CF swung from €-193m to €37m, clearly pushed by the divestment of Solvay’s stake in Inovyn, the European chlorovinyls joint ve
08 Nov 2016
Underlying figures look good – at first sight
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Underlying figures look good – at first sight
Solvay SA (SOLB:WBO) | 0 0 0.5% | Mkt Cap: 11,953m
- Published:
08 Nov 2016 -
Author:
Martin Schnee -
Pages:
3
Q3 sales rose +8% to €2,921m and the gross profit margin improved from 26.9% to 29.7%, based on IFRS. EBIT rocketed +67% to €360m and net profit attributable to shareholders ballooned by +71% to €176m. Conveying the better operating performance and higher D/A down the road, operating CF strongly increased by +31% to €522m. Investing CF swung from €-193m to €37m, clearly pushed by the divestment of Solvay’s stake in Inovyn, the European chlorovinyls joint ve